Abvc Biopharma (ABVC) EBIAT (2016 - 2025)
Historic EBIAT for Abvc Biopharma (ABVC) over the last 14 years, with Q3 2025 value amounting to -$1.3 million.
- Abvc Biopharma's EBIAT fell 16414.47% to -$1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.4 million, marking a year-over-year decrease of 384.0%. This contributed to the annual value of -$5.3 million for FY2024, which is 3649.15% up from last year.
- According to the latest figures from Q3 2025, Abvc Biopharma's EBIAT is -$1.3 million, which was down 16414.47% from -$2.3 million recorded in Q2 2025.
- Abvc Biopharma's 5-year EBIAT high stood at -$487431.0 for Q3 2024, and its period low was -$7.7 million during Q4 2021.
- Moreover, its 5-year median value for EBIAT was -$1.9 million (2022), whereas its average is -$2.5 million.
- As far as peak fluctuations go, Abvc Biopharma's EBIAT plummeted by 40928.62% in 2022, and later soared by 8552.79% in 2024.
- Abvc Biopharma's EBIAT (Quarter) stood at -$7.7 million in 2021, then surged by 40.14% to -$4.6 million in 2022, then surged by 84.81% to -$700309.0 in 2023, then decreased by 13.74% to -$796527.0 in 2024, then crashed by 61.64% to -$1.3 million in 2025.
- Its EBIAT was -$1.3 million in Q3 2025, compared to -$2.3 million in Q2 2025 and -$944190.0 in Q1 2025.